Renaissance Technologies’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Renaissance Technologies’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-298,400	Closed	-$8.34M	–	3870
2019 Q3	$8.34M	Buy	298,400 +144,700	+94%	+$2.34M	0.01%	1503
2019 Q2	$2.17M	Buy	153,700 +127,900	+496%	+$1.22M	﹤0.01%	2279
2019 Q1	$229K	Buy	+25,800	New	+$209K	﹤0.01%	3172

Renaissance Technologies's DOVA Position: Q4 2019 in Review

Renaissance Technologies sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 298,400 shares — an estimated $8.34M sold.

Renaissance Technologies first reported a position in DOVA in Q1 2019 and held it in 3 quarters. The position peaked at $8.34M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Renaissance Technologies reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Renaissance Technologies sold 298,400 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $8.34M.
Renaissance Technologies first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Renaissance Technologies's Dova Pharmaceuticals, Inc. Common Stock position peaked at $8.34M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.